StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Ultragenyx Pharmaceutical Inc.
NasdaqGS:RARE
Sector
Industries
Location
Market Cap
USD 3.43 B
Share Price
USD 36.26
Avg Daily Volume
934,614
Change (1 day)
-0.27%
Change (1 year)
-11.82%
Change (YTD)
-13.81%
Ultragenyx Pharmaceutical Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2025: USD 6.32
Ultragenyx Pharmaceutical Inc. Revenue Per Share is USD 6.32 for the Trailing 12 Months (TTM) ending March 31, 2025, a 9.89% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.
-
Ultragenyx Pharmaceutical Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 5.75, a 5.01% change year over year.
-
Ultragenyx Pharmaceutical Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 5.47, a 12.79% change year over year.
-
Ultragenyx Pharmaceutical Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 4.85, a -8.32% change year over year.
-
Ultragenyx Pharmaceutical Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 5.29, a 150.94% change year over year.
Competitors
AbbVie Inc.
USD 189.99
ABBV
+4.37
2.35%
Novo Nordisk A/S
USD 69.18
NOVO-B.CO
-0.07
-0.11%
Roche Holding AG
USD 347.88
RO.SW
+1.27
0.37%
Novartis AG
USD 123.49
NOVN.SW
+2.27
1.88%
Abbott Laboratories
USD 136.26
ABT
+0.25
0.18%
AstraZeneca PLC
USD 142.95
AZN.L
+3.99
2.87%
Merck & Co., Inc.
USD 81.81
MRK
+2.65
3.35%
Boston Scientific Corporation
USD 104.78
BSX
-2.63
-2.45%
Thermo Fisher Scientific Inc.
USD 421.47
TMO
+16.01
3.95%
Amgen Inc.
USD 290.52
AMGN
+11.31
4.05%
Gilead Sciences, Inc.
USD 111.73
GILD
+0.86
0.78%
Pfizer Inc.
USD 25.04
PFE
+0.80
3.30%
Sanofi
USD 98.07
SAN.PA
+1.17
1.21%
Vertex Pharmaceuticals Incorporated
USD 452.16
VRTX
+6.96
1.56%
Bristol-Myers Squibb Company
USD 47.51
BMY
+1.22
2.64%
Chugai Pharmaceutical Co., Ltd.
USD 49.50
4519.T
-0.96
-1.91%
GSK plc
USD 19.41
GSK.L
+0.32
1.70%
CSL Limited
USD 157.77
CSL.AX
+0.98
0.62%
Siemens Healthineers AG
USD 55.39
SHL.DE
-0.08
-0.14%
Regeneron Pharmaceuticals, Inc.
USD 534.91
REGN
+9.91
1.89%
Key Data
| Date | Revenue Per Share | Free Cash Flow Per Share | Dividend Per Share | Debt to Equity Ratio |
|---|
Competitors
AbbVie Inc.
USD 189.99
ABBV
+4.37
2.35%
Novo Nordisk A/S
USD 69.18
NOVO-B.CO
-0.07
-0.11%
Roche Holding AG
USD 347.88
RO.SW
+1.27
0.37%
Novartis AG
USD 123.49
NOVN.SW
+2.27
1.88%
Abbott Laboratories
USD 136.26
ABT
+0.25
0.18%
AstraZeneca PLC
USD 142.95
AZN.L
+3.99
2.87%
Merck & Co., Inc.
USD 81.81
MRK
+2.65
3.35%
Boston Scientific Corporation
USD 104.78
BSX
-2.63
-2.45%
Thermo Fisher Scientific Inc.
USD 421.47
TMO
+16.01
3.95%
Amgen Inc.
USD 290.52
AMGN
+11.31
4.05%
Gilead Sciences, Inc.
USD 111.73
GILD
+0.86
0.78%
Pfizer Inc.
USD 25.04
PFE
+0.80
3.30%
Sanofi
USD 98.07
SAN.PA
+1.17
1.21%
Vertex Pharmaceuticals Incorporated
USD 452.16
VRTX
+6.96
1.56%
Bristol-Myers Squibb Company
USD 47.51
BMY
+1.22
2.64%
Chugai Pharmaceutical Co., Ltd.
USD 49.50
4519.T
-0.96
-1.91%
GSK plc
USD 19.41
GSK.L
+0.32
1.70%
CSL Limited
USD 157.77
CSL.AX
+0.98
0.62%
Siemens Healthineers AG
USD 55.39
SHL.DE
-0.08
-0.14%
Regeneron Pharmaceuticals, Inc.
USD 534.91
REGN
+9.91
1.89%